Lung Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with a primary non-small cell lung cancer (a common type of lung cancer), where the tumour meets a certain minimum size based on standard cancer staging guidelines
- People whose tumour tissue sample (biopsy) is of good enough quality to measure a specific protein called PDL-1, which is used to guide some cancer treatments
- People who have had a CT scan for cancer staging where the spread to nearby lymph nodes is uncertain, but the presence or absence of spread to distant parts of the body has been clearly determined
Who may not be able to join:
- People who have a medical reason that means they cannot safely have an MRI scan or receive the type of dye (contrast agent) used during MRI imaging
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +390382503761
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
assessment of the ability of advanced magnetic resonance imaging techniques to distinguish between immune phenotypes in NSCLC.
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.